BioCentury
ARTICLE | Clinical News

PH80 nasally administered vomeropherin compound: Phase I

October 19, 1998 7:00 AM UTC

Pherin Pharmaceuticals Inc., Menlo Park, Calif. Product: PH80 nasally administered vomeropherin compound Indication: Treat premenstrual syndrome (PMS) Status: Pherin and partner N.V. Organon will beg...